Biotech Stocks

MYL Earnings Momentum Propels Mylan Stock to a Buy

Biogeneric drugmaker Mylan is undergoing soaring growth based on its backlog of generics waiting for U.S government approval to market. Mylan stock is a buy More 

5 Biotech Stocks That Are Buyout Candidates

These biotech stocks are this year's top M&A candidates. But even if they're not acquired, they're solid biopharma investments. More 

This Biotech Bubble Is Bound to Burst

Biotech stocks have been hot thanks to a wave of M&A speculation. That wave, however, has run its course, putting these stocks and biotech ETFs at risk. More 

Regeneron: REGN Stock Takes Out All the Stops

After already rallying for a few days, REGN stock on Tuesday shifted into a new gear and broke out to new all-time highs. What's next for Regeneron? More 

Trade of the Day: Stemline Therapeutics (STML)

Technicals can certainly give insight into big-name stocks–but they really shine in finding the best stocks to buy that might not have crossed your radar. More 

Among Biotechs, Amgen Stock Offers Dividend Income

Biotech giant AMGN has a nice benefit Amgen stock in that it pays a dividend. With a low payout ratio, investors should look for increases in the future. More 

Healthcare Stocks: No Longer a Sure Thing

Healthcare stocks have outperformed in recent years, but investors need to be selective with valuations that now are at richer levels. More 

AMGN: Amgen Stock Future Looks Bright for Investors

Amgen released earnings that put a smile on investor's faces, and Amgen stock looks like a solid buy for the long term More 

ILMN Stock – The New Illumina Human Genome Machine Is a Game Changer

Illumina says it has developed a DNA sequencing machine that can scan a genome for under $1,000, sending ILMN stock higher. More 

5 Biotech Stocks With Big Catalysts on the Horizon

Announcements from, or about, these biotech stocks could greatly inflate their values ... or completely deflate them. More